What scientists have learnt from talking to thousands of long COVID patients
There are still so many things we don’t fully understand about COVID, but one of the big mysteries is long COVID. Experienced by up to 30 per cent of people […]
Australia’s expert advisory group on vaccines has recommended the COVID-19 vaccine be deferred for people who have a history of specific rare blood clotting disorders.
The Australian Technical Advisory Group on Immunisation says for the time being it recommends that vaccination with any COVID-19 vaccine should be deferred for people who have a history of two very rare and specific conditions.
This is the first time a warning has been given for COVID-19 vaccines in Australia, and the recommendation applies to both Pfizer and AstraZeneca vaccines, although the current concerns have been focussed on the latter.
So on today’s Coronacast, why has the expert panel decided to make this move now? And for the very small number of people affected, what should they keep an eye out for if receiving a vaccine?
Also on today’s show:
* AstraZeneca releases more figures regarding its vaccine’s effectiveness
And the return of Quick Fire Friday!
Previous episode
Post comments (0)